Final Program

SUNDAY • MAY 15 123
221 Acid and Non-Acid Reflux in Idiopathic Pulmonary Fibrosis/T.
Lee, L. Liu, S. Shapera, T.K. Marras, J.H. Fisher, Toronto, Canada,
p.A2709
222 Effects of Emphysema on Physiologic and Prognostic
Characteristics in Idiopathic Pulmonary Fibrosis/T. Kim, S.M.
Lee, N. Kim, J.B. Seo, J.W. Song, Seoul, Korea, Republic of,
p.A2710
223 Prognostic Value of Plasma Leptin in Acute Exacerbation
Idiopathic Pulmonary Fibrosis/M. Cao, J. Swigris, H. Cai,
Nanjing, China, p.A2711
224 Idiopathic Pulmonary Fibrosis in Patients with Possible Usual
Interstitial Pneumonia Pattern on High-Resolution CT/Y.
Kondoh, H. Taniguchi, T. Suda, T. Fujisawa, M. Arita, K. Ichikado,
K. Kishi, T. Kishaba, O. Nishiyama, T. Ogura, S. Homma, Seto,
Japan, p.A2712
225 Reduction in Non-Elective Respiratory-Related Hospitalizations
in Patients Treated with Pirfenidone: Pooled Analyses from
Three Phase 3 Trials of Pirfenidone in Idiopathic Pulmonary
Fibrosis/J. Swigris, B.J. Ley, B.-M. Day, J. Stauffer, W. Chou, K.
Raimundo, H.R. Collard, Denver, CO, p.A2713
A104
POSTER DISCUSSION SESSION
CRITICAL CARE: SEPSIS TRANSLATIONAL
INSIGHTS
2:15 p.m. - 4:15 p.m. MOSCONE CENTER
Room 3001 (West Building, Level 3)
Poster Viewing 2:15-3:00
Discussion 3:00-4:15
Chairing: M.M. Wurfel, MD, PhD, Seattle, WA
W. Fang, MD, Kaohsiung, Taiwan
E.P. Schmidt, MD, Aurora, CO
701 Identifying Time-Dependent Mortality Signatures in Cases of
Suspected Infection Using Scalable Predictive Models/M.B.
Mayhew, A.P. Sales, J.D. Greene, J.M. Baker, A. Santucci, G.J.
Escobar, V. Liu, T. Wasson, Livermore, CA, p.A2714
702 Regulation of Creb-Binding Protein
Ubiquitination-Deubiquitination Modulates Histone Acetylation
and Systemic Inflammation/Y. Zhao, S. Dong, J. Wei, R.K. Boswer,
A. Khoo, L. Zhang, A.M. Jacko, J. Zhao, Pittsburgh, PA, p.A2715
703 Circulating Levels of Interleukin-17A Are Associated with
Mortality and Organ Dysfunction in Sepsis/C. Mikacenic, S.
Harju-Baker, V. Dmyterko, M.M. Wurfel, Seattle, WA, p.A2716
704 Heterogeneous Treatment Effect of Recombinant Human
Interleukin-1 Receptor Antagonist for Human Severe Sepsis/N.J.
Meyer, T.G. Dunn, J.P. Reilly, J.A. Palakshappa, R. Feng, J.D.
Christie, J.E. Palardy, S.M. Opal, Philadelphia, PA, p.A2717
705 Reduced PCSK9 Function Is Associated with Improved Outcomes
in Gram-Positive Septic Shock Patients/E. Topchiy, C. Fjell, J.A.
Russell, J.H. Boyd, K.R. Walley, Vancouver, Canada, p.A2718
706 Lipopolysaccharide Is Cleared from the Circulation by
Hepatocytes Via the Low Density Lipoprotein Receptor/E. Topchiy,
J.H. Boyd, J.A. Russell, K. Walley, Vancouver, Canada, p.A2719
707 Inheritance of Loss-of-Function Tryptase Alleles Is Linked to
Reduced Survival from Severe Sepsis/N. Trivedi, R. Ahuja, K.
Walley, M. Babina, S. Guhl, G. Caughey, San Francisco, CA, p.A2720
708 Modulation of Annexin A2 Expression in Human Sepsis/M.
Bender, F. West, J. Lanfranco, H. Chen, D. Almeida, D. Berlin, K.A.
Hajjar, New York, NY, p.A2721
709 High Levels of Methylarginines Are Associated with Increased
Mortality in Patients with Severe Sepsis/K.M. Mortensen, T.S.
Itenov, N. Haase, R. Muller, S.R. Ostrowski, P.I. Johansson, N.V.
Olsen, A. Perner, P. Soe-Jensen, M. Bestle, Hillerod, Denmark,
p.A2722
710 Plasma Asymmetric Dimethylarginine (ADMA) Association
with Risk of Death in Septic Shock - Subgroup Analysis of
Patients from the VANISH Trial/S. Lambden, J. Leiper, A.
Gordon, London, United Kingdom, p.A2723
711 Increased Receptor Interacting Serine/Threonine-Protein
Kinase 3 Plasma Levels Is Associated with Severity of
Sepsis/K.C. Ma, M. Pabon, E.J. Schenck, E. Finkelsztein, A.
Hernandez, D. Berlin, K. Nakahira, A.M.K. Choi, New York, NY,
p.A2724
712 Impaired Immune Response and Lower Serum
Monocyte/Neutrophil Ratio Can Predict Outcomes in Patients
with Severe Sepsis/W.-F. Fang, H.-C. Kao, Y.-T. Fang, K.-T.
Huang, Y.-H. Wang, C.-H. Huang, Y.-T. Chang, H.-L. Huang, C.-C.
Wang, M.-C. Lin, Kaohsiung, Taiwan, p.A2725
713 Early High Density Lipoprotein (HDL) Level Predicts the
Development of Organ Dysfunction and Mortality in Patients
Presenting with Suspected Sepsis/M. Cirstea, K. Walley, J.
Russell, J. Boyd, Vancouver, Canada, p.A2726
714 Randomised Controlled Trial of Granulocyte Macrophage
Colony Stimulating Factor in Critically Ill Patients with
Impaired Neutrophil Function/E.M. Pinder, A.J. Rostron, T.P.
Hellyer, M.-H. Ruchaud-Sparagano, J. Scott, J.G. Macfarlane, S.
Wiscombe, J.D. Widdrington, T. Allen, A.I. Roy, V.C. Linnett, S.V.
Baudouin, S.E. Wright, T. Chadwick, A. Fouweather, S. Bowett, J.
Parker, P.A. Corris, D.F. D. McAuley, A. Conway Morris, A.
Simpson, Newcastle upon Tyne, United Kingdom, p.A2727
715 Hydrocortisone Treatment Decreases Nitric Oxide Levels and
Increases Blood Pressure and Survival Following B. anthracis
Cell Wall Peptidoglycan Challenge in Rats/D.A. Suffredini, X.
Cui, Y. Li, Y. Fitz, P. Eichacker, Bethesda, MD, p.A2728
716 PCSK9 Loss-of-Function Genotype and Outcomes of Sepsis/K.
Roveran Genga, M. Cirstea, C. Lo, K. Walley, J.A. Russell, J.H.
Boyd, Vancouver, Canada, p.A2729
717 Adipokines Early in Critical Illness/A.M. Ahasic, M. Pisani, New
Haven, CT, p.A2730
718 Acute Respiratory Distress Syndrome Does Not Independently
Predict Mortality Among All Critically Ill Patients with
Sepsis/C.L. Auriemma, H. Zhuo, T. Deiss, T. Liu, M. Lippi, K.R.
Famous, E. Seeley, K.N. Kangelaris, A. Gomez, M. Matthay, K. Liu,
C.S. Calfee, San Francisco, CA, p.A2731
SUNDAY AFTERNOON
ATS 2016 • San Francisco